Cargando…
The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1
BACKGROUND: The ability to distinguish hepatocellular carcinoma (HCC) from metastatic carcinoma (MC) involving the liver and cholangiocarcinoma (CC) by immunohistochemistry has been limited by the lack of a reliable positive marker for hepatocellular differentiation. Arginase-1 is a marker for HCC r...
Autores principales: | Radwan, Nehal A, Ahmed, Naglaa S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500209/ https://www.ncbi.nlm.nih.gov/pubmed/23111165 http://dx.doi.org/10.1186/1746-1596-7-149 |
Ejemplares similares
-
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection
por: Abbate, Valeria, et al.
Publicado: (2017) -
Diagnostic Value of Arginase-1 and Glypican-3 in Differential Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Metastatic Carcinoma of Liver
por: Geramizadeh, Bita, et al.
Publicado: (2015) -
Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
por: Lennartz, Maximilian, et al.
Publicado: (2021) -
Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
por: Li, Yuan, et al.
Publicado: (2020) -
Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma
por: Wang, Congrong, et al.
Publicado: (2020)